Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 2/20 | 0.35 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.32 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.32 |
| ▸ | POLB | P06746 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21012062 | 1.00 | TSHR (0.35) | TSHRALDH1A1EPHX2POLB | |
| SCHEMBL19153178 | 0.91 | TSHR (0.35) | TSHR | |
| SCHEMBL19153627 | 0.91 | TSHR (0.31) | TSHR | |
| SCHEMBL20386871 | 0.89 | TSHR (0.35) | TSHR | |
| SCHEMBL18239106 | 0.86 | TSHR (0.35) | TSHR | |
| SCHEMBL25763425 | 0.84 | TSHR (0.41) | TSHR | |
| SCHEMBL19705935 | 0.82 | L3MBTL1 (0.31) | — | |
| SCHEMBL18227302 | 0.81 | TSHR (0.32) | TSHR | |
| SCHEMBL19541808 | 0.81 | ALDH1A1 (0.34) | TSHRALDH1A1EPHX2POLB | |
| SCHEMBL19249810 | 0.81 | TSHR (0.33) | TSHRALDH1A1EPHX2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20220184104-A1 | SILANOL BASED THERAPEUTIC PAYLOADS | BLINKBIO INC (US) | 2022-06-16 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220184104-A1 | SILANOL BASED THERAPEUTIC PAYLOADS | CD47, CD4, BST2 | TSHR 3437/4885ALDH1A1 1176/4885EPHX2 2871/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.